Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical AKL in PLO gel for Neuropathic Pain from Radiation Skin Reactions
NCT00798083Phase 3Completed
- Sponsor
- BC Cancer
- Start
- Apr 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amitriptyline, ketamine transdermal patch, lidocaine 10% oropharyngeal spray in neuropathic pain, sponsored by BC Cancer. Started Apr 2008; status: completed.
02
Drugs
amitriptylineketamine transdermal patchlidocaine 10% oropharyngeal spray
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00798083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00798083.